Alberta Investment Management Corp Bellus Health Inc. Transaction History
Alberta Investment Management Corp
- $10.2 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding BLU
# of Institutions
1Shares Held
128KCall Options Held
0Put Options Held
0About BELLUS Health Inc.
- Ticker BLU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 125,793,000
- Description
- BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...